Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Circulating immune complexes in multiple sclerosis].

J Losy1, M Wender

  • 1Katedry i Kliniki Neurologii AM w Poznaniu.

Neurologia I Neurochirurgia Polska
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic syndrome in type 1 diabetes mellitus. Does it have any impact on the course of pregnancy?

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2011
Same author

IgG subclasses and their intrathecal synthesis in patients with amyotrophic lateral sclerosis.

European journal of neurology·2011
Same author

The associations between iL-18 serum levels and the prevalence of metabolic syndrome in Polish men over the age of 40 according to other selected inflammatory indices and androgens: comparison of NCEP with IDF criteria.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2011
Same author

Concentration of chemokines in peripheral blood in first trimester of diabetic pregnancy.

Acta obstetricia et gynecologica Scandinavica·2007
Same author

PECAM-1, a key player in neuroinflammation.

European journal of neurology·2006
Same author

The level of chemokine CXCL5 in the cerebrospinal fluid is increased during the first 24 hours of ischaemic stroke and correlates with the size of early brain damage.

Folia morphologica·2006
Same journal

Association of serum homocysteine, folate, and vitamin B₁₂ levels with cognitive function in levodopa-naïve patients with Parkinson's disease and mild cognitive impairment.

Neurologia i neurochirurgia polska·2026
Same journal

Advances in CSF1R-related disorder: novel mutations, dopaminergic imaging, and overcoming underdiagnosis.

Neurologia i neurochirurgia polska·2026
Same journal

Electrophysiological markers of subclinical central nervous system involvement in patients with non-small-cell lung cancer without brain metastases.

Neurologia i neurochirurgia polska·2026
Same journal

Highlighting the CSF1R mutational spectrum: c.2549C>T variant in late-onset leukoencephalopathy mimicking multiple sclerosis.

Neurologia i neurochirurgia polska·2026
Same journal

Sacroiliac joint manipulation for low back and radicular pain: outcomes in a 100-patient single-center cohort.

Neurologia i neurochirurgia polska·2026
Same journal

Beyond leukodystrophy: parkinsonism and microglial failure in CSF1R p.Ile794Thr.

Neurologia i neurochirurgia polska·2026
See all related articles

Circulating immunocomplexes are prevalent in multiple sclerosis (MS) patients, detected in 71% of cases. Higher concentrations were observed in the chronic-progressive MS course compared to the relapse-remitting form.

Area of Science:

  • Immunology
  • Neurology

Context:

  • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Circulating immunocomplexes (CICs) are immune aggregates implicated in various autoimmune conditions.

Purpose:

  • To investigate the presence and concentration of circulating immunocomplexes in patients with multiple sclerosis.
  • To compare CIC levels between different MS disease courses (relapse-remitting vs. chronic-progressive) and healthy controls.

Summary:

  • A solid-phase ELISA anti-C3 method detected circulating immunocomplexes in 71% of 21 MS patients.
  • CIC positivity was observed in 73% of relapse-remitting MS and 66% of chronic-progressive MS cases, versus 5% in controls.
  • Serum CIC concentration was significantly higher in chronic-progressive MS (62 ± 4 µg/ml) than in relapse-remitting MS (40.1 ± 5.1 µg/ml).

Related Experiment Videos

Impact:

  • These findings suggest that circulating immunocomplexes may serve as a potential biomarker in multiple sclerosis.
  • Quantifying CIC levels could aid in differentiating MS disease courses and understanding disease pathogenesis.